⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28352240 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL11172486 | 0.87 | — | — | |
| SCHEMBL28224577 | 0.87 | — | — | |
| SCHEMBL11582709 | 0.87 | — | — | |
| SCHEMBL76203 | 0.82 | — | — | |
| SCHEMBL2347475 | 0.82 | — | — | |
| SCHEMBL7151038 | 0.82 | — | — | |
| SCHEMBL2351926 | 0.82 | — | — | |
| SCHEMBL1645015 | 0.82 | — | — | |
| SCHEMBL1873213 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2344487-A1 | HEPATITIS C INHIBITOR COMPOUNDS | Boehringer Ingelheim International GmbH (DE) | 2011-07-20 | — | — | EP | disclosed |
| EP-2313086-A2 | CONTROLLED RELEASE TOPIRAMATE FORMULATIONS USING INTELLIGENT POLYMERS | BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010034105-A1 | HEPATITIS C INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010015567-A2 | CONTROLLED RELEASE FORMULATIONS USING INTELLIGENT POLYMERS | BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) | 2010-02-11 | — | — | WO | disclosed |
| CN-1092067-A | Quinazoline derivant and preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-09-14 | — | — | CN | disclosed |